Thibaut Chalopin
Pierre-la-treiche, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723].
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 16, 2021
Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 19, 2017
Investigation of a new "N2S2O2" chelating agent with high Po(iv) affinity.
Journal: Chemical communications (Cambridge, England)
Published: June 02, 2017
Second generation of thiazolylmannosides, FimH antagonists for E. coli-induced Crohn's disease.
Journal: Organic & biomolecular chemistry
Published: April 05, 2016
Differentiation of Crohn's Disease-Associated Isolates from Other Pathogenic Escherichia coli by Fimbrial Adhesion under Shear Force.
Journal: Biology
Published: January 28, 2016
The Antiadhesive Strategy in Crohn's Disease: Orally Active Mannosides to Decolonize Pathogenic Escherichia coli from the Gut.
Journal: Chembiochem : a European journal of chemical biology
Published: January 12, 2016
Inhibition profiles of mono- and polyvalent FimH antagonists against 10 different Escherichia coli strains.
Journal: Organic & biomolecular chemistry
Published: October 07, 2015
Thiazolylaminomannosides as potent antiadhesives of type 1 piliated Escherichia coli isolated from Crohn's disease patients.
Journal: Journal of medicinal chemistry
Published: June 26, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026